Drug prices based on effectiveness
Some drug makers are adjusting what they'll charge patients for their drugs based on the effectiveness of the medicines. Joel Rose reports.
The employee entrance at the headquarters for drug maker Merck in Whitehouse Station, N.J. (Chris Hondros/Getty Images)
More on Health
TEXT OF STORY
Kai Ryssdal: Big pharma is putting its money where its mouth is. Today the drug maker Merck announced a new pricing deal with health insurer Cigna. Merck says it's going to adjust the price of its two diabetes drugs based on whether patient health actually improves. Joel Rose reports on pharmaceutical pay for performance.
JOEL ROSE: Traditionally drug companies offer discounts based on how often their drug is prescribed -- not how well it actually works. The deal announced today between Merck and Cigna is different.
ERIC Elliott: Because it drives the right-end result from all perspectives.
Eric Elliott is president of Cigna pharmacy management. He says Merck will charge Cigna less for two diabetes drugs, Januvia and Janumet but only if patients get their blood sugar under control.
Elliott: A health plan will benefit from overall medical outcomes. And individuals will benefit through better outcomes for themselves.
And Merck stands to profit from the deal, too, even though it's cutting prices. Fiona Scott Morton teaches economics at the Yale School of Management. She says that's because Merck is counting on selling a lot more pills.
Scott Morton: If an insurance company will really get aggressive in making sure their patients take the drug and get refills for the drug, then the quantity I sell to that insurance company is going to go up. In addition, the people who are supposed to be taking the drug are actually taking it.
The health-care industry is experimenting with other kinds of pay-for-performance deals. Procter & Gamble just announced what's essentially a money-back guarantee on its new osteoperosis drug, Actonel. Dan Hecht manages P&G's pharmaceutical business in North America.
DAN Hecht: We're standing behind our product. If somebody has been taking Actonel for six months, and if they suffered from a fracture, we would reimburse for the cost of that fracture.
Up to $30,000, in the case of a fractured hip. Hecht says the pilot program could expand to other parts of the country -- if it breaks even.
I'm Joel Rose, for Marketplace.
Comments
Comment | Refresh
From Dallas, TX, 05/15/2009
Generic medications are a great way to keep your prescription drug costs down. What really gets my goat is these new drugs where they put two generics together and then charge an arm and a leg for it! I’ve seen ads on TV for Caduet. It has two ingredients. One is Amlodipine and the other is Atorvastatin. With my RxDrugCard I can get 30 tablets of Amlodipine for $9 and 30 tablets of Simvastatin for $9. I’ll bet they are charging more than $18 for this! The unthinking public is going to pressure their doctors into giving them something just because it’s new, when something old or generic would do the job for cheaper.
Post a Comment: Please be civil, brief and relevant.
Email addresses are never displayed, but they are required to confirm your comments. All comments are moderated. Marketplace reserves the right to edit any comments on this site and to read them on the air if they are extra-interesting. Please read the Comment Guidelines before posting.
You must be 13 or over to submit information to American Public Media. The information entered into this form will not be used to send unsolicited email and will not be sold to a third party. For more information see Terms and Conditions and Privacy Policy.